Difference Between Nitrofurantoin Crystals and Macrobid
Macrobid is a specific brand name formulation of nitrofurantoin that contains both nitrofurantoin macrocrystals and nitrofurantoin monohydrate in a dual-release formulation, while nitrofurantoin macrocrystals alone is a different formulation with different pharmacokinetic properties. 1, 2
Formulation Differences
- Nitrofurantoin macrocrystals is a single-component formulation with larger crystal size that dissolves more slowly, typically dosed as 50-100 mg four times daily for UTIs 1
- Macrobid (nitrofurantoin monohydrate/macrocrystals) is a dual-release formulation that combines:
Clinical Applications
- Both formulations are recommended as first-line agents for uncomplicated urinary tract infections by major guidelines including IDSA and European Association of Urology 1, 3
- Macrobid (nitrofurantoin monohydrate/macrocrystals) is the most commonly recommended formulation in current guidelines with a standard dose of 100 mg twice daily for 5 days 1, 2
- Clinical efficacy is similar between formulations:
Pharmacokinetic Considerations
- Crystal size affects absorption, distribution, and excretion patterns 4
- The dual-release formulation of Macrobid provides more consistent drug levels with less frequent dosing 4, 5
- Both formulations achieve high urinary concentrations needed for bactericidal activity 4
- Both formulations have similar contraindications in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased toxicity risk 3, 2
Dosing Differences
- Nitrofurantoin macrocrystals: 50-100 mg four times daily for 5-7 days 1
- Macrobid (nitrofurantoin monohydrate/macrocrystals): 100 mg twice daily for 5 days 1, 2
- The improved convenience of twice-daily dosing with Macrobid may enhance patient adherence compared to the four-times-daily dosing of macrocrystals alone 2
Common Side Effects
- Both formulations share similar side effect profiles:
Clinical Decision-Making
- For standard uncomplicated UTI treatment, Macrobid (nitrofurantoin monohydrate/macrocrystals) at 100 mg twice daily for 5 days is the preferred formulation due to convenience and guideline support 1, 2
- Both formulations should be avoided in patients with CrCl <60 mL/min 3, 2
- Alternative agents should be considered for patients with renal impairment, including trimethoprim-sulfamethoxazole or fosfomycin trometamol 2